• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER KNEE CREATIONS, INC. SUBCHONDROPLASTY; SCP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER KNEE CREATIONS, INC. SUBCHONDROPLASTY; SCP Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Necrosis (1971)
Event Date 03/07/2018
Event Type  Injury  
Manufacturer Narrative
It was reported that a year after an initial subchondroplasty procedure, the patient was diagnosed with avascular necrosis of the talus.The investigation is ongoing.Once additional information becomes available, a supplemental report will be submitted.
 
Event Description
Avn after scp.
 
Manufacturer Narrative
The initial subchondroplasty procedure was performed on (b)(6) 2018.A year later, the patient was presented with avascular necrosis of the talus with the notification date of (b)(6) 2019.A postoperative mri was provided for review.The procedure was reviewed with the site's clinical advisory board, who stated that the target site was a subtalar osteochondral lesion with cystic change and surrounding bml and that the patient was a good candidate for scp.The lesion location corresponds closely to the blood supply from the posterior tibial artery - the only supply to the talar body (the talus, like the navicular, has a famously tenuous blood supply and is prone to avn).The injection was determined to be in the correct spot, and the injected volume appeared to be about 3-5cc was injected.The clinical opinion was that too much accufill was injected into the talus during this procedure, leading to the clinical changes.The volume recommendation in scp surgical technique guide and surgical courses for scp treatment of the talar body is 1 to 1 ½ cc of accufill.This complaint is being closed based on surgical technique.The responsible surgeon has been made aware of these findings.The product was not returned for evaluation, as it remains implanted in the patient.The dhr for the raw material and finished goods lot was reviewed, and no anomalies related to the complaint condition were noted.
 
Event Description
Avn after scp.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUBCHONDROPLASTY
Type of Device
SCP
Manufacturer (Section D)
ZIMMER KNEE CREATIONS, INC.
841 springdale drive
exton PA 19341
MDR Report Key8489017
MDR Text Key141108939
Report Number3008812173-2019-00018
Device Sequence Number1
Product Code OJH
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 07/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/01/2019
Device Model NumberN/A
Device Catalogue Number514.503
Device Lot NumberKC03668
Was the Report Sent to FDA? No
Distributor Facility Aware Date03/21/2019
Device Age28 MO
Event Location Hospital
Date Manufacturer Received03/21/2019
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age69 YR
-
-